Comparing Nintedanib vs Prednisone
| Nintedanib | Prednisone |
|
|---|
| Nintedanib | Prednisone |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis, Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease. Nintedanib may also be... View more |
Prescription only
Prednisone effectively controls inflammation and an overactive immune system but may not be suitable for everybody. Long-term use is limited by potentially severe side effects such as adrenal... View more |
||||||||
| More about Nintedanib | More about Prednisone | ||||||||
| Ratings & Reviews | |||||||||
|
Nintedanib has an average rating of 7.7 out of 10 from a total of 36 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 6% reported a negative effect. |
Prednisone has an average rating of 7.5 out of 10 from a total of 871 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Nintedanib side effects |
View all Prednisone side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Prednisone prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Ofev | Rayos | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
9.5 hours |
4 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 252 drugs are known to interact with Nintedanib:
|
A total of 628 drugs are known to interact with Prednisone:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
|||||||||
| First Approval Date | |||||||||
|
N/A |
February 21, 1955 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ofev
Ofev (nintedanib) is used to treat a lung disease called idiopathic pulmonary fibrosis, and ...
Esbriet
Esbriet ((pirfenidone) may be used to treat adults with idiopathic pulmonary fibrosis (IPF), a lung ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.